The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer
Calibrators for HE4 and HER2 Tumor Marker Assays | Clinical Lab Products
HE4 is overexpressed and secreted as a glycoprotein by ovarian... | Download Scientific Diagram
Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library
HE4 (Human epididymis protein) | Най-добрите лекари в България MediPro.bg
PDF] Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo | Semantic Scholar
ROC plot and AUC for CA125 and HE4 for patients with epithelial ovarian... | Download Scientific Diagram
Tumour marker HE4 and CA125 in ovarian cancer - Sullivan ...
Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer - ScienceDirect
Comparative analysis of both markers, HE4 and CA125, as prognostic factors. | Download Scientific Diagram
Electrochemical immunomagnetic assay as biosensing strategy for determination of ovarian cancer antigen HE4 in human serum - ScienceDirect
Table I from The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer | Semantic Scholar
call platform water the flower he4 tumor marker normal range puberty Botany animal
HE4 | Fujirebio
call platform water the flower he4 tumor marker normal range puberty Botany animal
DOC) HE4, A New Potential Tumor Marker for Early Diagnosis and Predicting of Breast Cancer Progression | Iranian Journal of Pathology - Academia.edu
PDF) HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | Jose Miguel Escudero - Academia.edu
HE4 & CA125 serum levels in patients with EOC according to tumor stage... | Download Table
Marker HE4 - kiedy warto wykonać badanie? Normy i interpretacja wyników - PoradnikZdrowie.pl
call platform water the flower he4 tumor marker normal range puberty Botany animal
Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer? | Bentham Science